Search…

Lates News

30/04/2026

Every economics AI news report, China Post Securities released a research report on April 30 stating that National Pharmaceutical (605507.SH) was given a "buy" rating. The main reasons for the rating include: 1) the animal health sector shows scale barriers and cyclical resilience, with rapid increases in fluoxetine and doxycycline hydrochloride; 2) product expansion and global certification accelerate, building a platform revenue matrix. (Daily Economic News)

Latest

3 m ago

US media: Trump will sign an executive order to expand the coverage of employee retirement savings plans.

3 m ago

The new selection rules emphasize again that analysts are strictly prohibited from using the past performance of individual stocks as a benchmark.

3 m ago

According to a research report released by Pacific Securities on April 30, Poly Development (600048.SH) was given a "buy" rating. The main reasons for the rating include: 1) pressure on revenue and net profit attributable to the parent company year-on-year; 2) a slight decrease in sales scale due to industry downturn; 3) focus on acquiring land in core cities with high-quality land resources. (China Economic Net)

3 m ago

The translation is: "Sino Land (00412.HK): Howard Kan Appointed as Executive Director"

4 m ago

According to AI Express, Dongwu Securities issued a research report on April 30, giving a "buy" rating to Hongfa Shares (600885.SH) with a target price of 39.8 yuan. The rating reasons mainly include: 1) high-voltage direct current & power & industry & signal achieving rapid growth; 2) power & automotive relays achieving steady growth; 3) "75+" strategic new stage, new business achieving stage results; 4) stable cost control ability, operating cash flow under greater pressure. (Daily Economic News)

See all latest